Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 61,765 | 44,573 | 105,921 | 77,566 |
| General And Administrative Expense | 61,765 | 44,573 | 79,855 | 77,566 |
| Other Operating Expenses | 9,931 | 1,086 | 8,147 | 11,857 |
| Operating Expense | 71,696 | 45,659 | 114,068 | 89,423 |
| Operating Income | -71,696 | -45,659 | -114,068 | -89,423 |
| EBIT | -71,696 | -45,659 | -114,068 | -89,423 |
| Interest Income | -- | 0.00 | 0.00 | 3,102 |
| Interest Income Non Operating | -- | 0.00 | 0.00 | 3,102 |
| Net Interest Income | -- | 0.00 | 0.00 | 3,102 |
| Other Income Expense | -- | -- | 66,000 | -- |
| Special Income Charges | 0.00 | -- | 0.00 | 0.00 |
| Pretax Income | -71,696 | -45,659 | -48,068 | -86,321 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Income From Continuing Operation Net Minority Interest | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Income Including Noncontrolling Interests | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Income Common Stockholders | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Income | -71,696 | -45,659 | -48,068 | -86,321 |
| EBITDA | -71,696 | -45,659 | -114,068 | -89,423 |
| Normalized EBITDA | -71,696 | -45,659 | -114,068 | -89,423 |
| Basic EPS | -0.01 | -0.01 | -- | -0.02 |
| Diluted EPS | -0.01 | -0.01 | -- | -0.02 |
| Basic Average Shares | 5.6M | 5.5M | -- | 5.3M |
| Diluted Average Shares | 5.6M | 5.5M | -- | 5.3M |
| Total Unusual Items | 0.00 | -- | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.00 | -- | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -71,696 | -45,659 | -48,068 | -86,321 |
| Diluted NI Availto Com Stockholders | -71,696 | -45,659 | -48,068 | -86,321 |
| Impairment Of Capital Assets | 0.00 | -- | 0.00 | 0.00 |
| Net Income Continuous Operations | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Non Operating Interest Income Expense | -- | 0.00 | 0.00 | 3,102 |
| Other Gand A | 61,765 | 44,573 | 79,855 | 77,566 |
| Salaries And Wages | -- | -- | 0.00 | 0.00 |
| Total Expenses | 71,696 | 45,659 | 114,068 | 89,423 |
| Total Operating Income As Reported | -71,696 | -45,659 | -114,068 | -89,423 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 115,020 | 190,476 | 239,821 | 439,501 |
| Cash Cash Equivalents And Short Term Investments | 115,020 | 190,476 | 239,821 | 439,501 |
| Receivables | 5,847 | 3,418 | 20,191 | 5,668 |
| Current Assets | 120,867 | 193,894 | 260,012 | 445,169 |
| Net PPE | 1.2M | 889,736 | 889,736 | 803,827 |
| Total Non Current Assets | 1.2M | 889,736 | 889,736 | 803,827 |
| Total Assets | 1.3M | 1.1M | 1.1M | 1.2M |
| Accounts Payable | -- | -- | 56,810 | 41,990 |
| Payables | -- | -- | 56,810 | 41,990 |
| Payables And Accrued Expenses | 35,020 | 36,351 | 56,810 | 41,990 |
| Other Current Liabilities | -- | -- | -- | 66,000 |
| Current Liabilities | 35,020 | 36,351 | 56,810 | 107,990 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 35,020 | 36,351 | 56,810 | 107,990 |
| Common Stock | 6.2M | 5.9M | 5.9M | 6.0M |
| Capital Stock | 6.2M | 5.9M | 5.9M | 6.0M |
| Additional Paid In Capital | 1.8M | 1.8M | 1.8M | 1.7M |
| Retained Earnings | -6.7M | -6.6M | -6.6M | -6.5M |
| Common Stock Equity | 1.3M | 1.0M | 1.1M | 1.1M |
| Stockholders Equity | 1.3M | 1.0M | 1.1M | 1.1M |
| Total Equity Gross Minority Interest | 1.3M | 1.0M | 1.1M | 1.1M |
| Total Capitalization | 1.3M | 1.0M | 1.1M | 1.1M |
| Net Tangible Assets | 1.3M | 1.0M | 1.1M | 1.1M |
| Tangible Book Value | 1.3M | 1.0M | 1.1M | 1.1M |
| Working Capital | 85,847 | 157,543 | 203,202 | 337,179 |
| Invested Capital | 1.3M | 1.0M | 1.1M | 1.1M |
| Share Issued | 6.0M | 5.5M | 5.5M | 5.5M |
| Ordinary Shares Number | 6.0M | 5.5M | 5.5M | 5.5M |
| Dueto Related Parties Current | -- | -- | 0.00 | 0.00 |
| Taxes Receivable | 5,847 | 3,418 | 20,191 | 5,668 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Operating Cash Flow | -75,456 | -49,345 | -113,771 | -19,260 |
| Cash Flow From Continuing Operating Activities | -75,456 | -49,345 | -113,771 | -19,260 |
| Stock Based Compensation | -- | -- | 0.00 | -- |
| Change In Working Capital | -3,760 | -3,686 | 297.00 | 67,061 |
| Change In Receivables | -2,429 | 16,773 | -14,523 | -1,758 |
| Change In Payables And Accrued Expense | -1,331 | -20,459 | 14,820 | 18,819 |
| Change In Payable | -1,331 | -20,459 | 14,820 | 18,819 |
| Capital Expenditure | -- | -- | -85,909 | -200,000 |
| Purchase Of PPE | 0.00 | 0.00 | -85,909 | -200,000 |
| Net PPE Purchase And Sale | 0.00 | 0.00 | -85,909 | -200,000 |
| Investing Cash Flow | 0.00 | 0.00 | -85,909 | -200,000 |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | -85,909 | -200,000 |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes In Cash | -75,456 | -49,345 | -199,680 | -219,260 |
| Beginning Cash Position | 190,476 | 239,821 | 439,501 | 658,761 |
| End Cash Position | 115,020 | 190,476 | 239,821 | 439,501 |
| Free Cash Flow | -75,456 | -49,345 | -199,680 | -219,260 |
| Asset Impairment Charge | -- | -- | 0.00 | 0.00 |
| Change In Account Payable | -1,331 | -20,459 | 14,820 | 19,219 |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -71,696 | -45,659 | -48,068 | -86,321 |
| Net Other Financing Charges | -- | -- | 0.00 | 0.00 |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | -- |